Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Natural Alternatives International, Inc. (NAII : NSDQ)

• Company Description    NATURAL ALTERNATIVES INTL INC is engaged in the formulation and production of encapsulated vitamins and nutrients and provides for its clients assistance with foreign registration of products, graphic design, brochures, formulations and a host of other marketing related services. Number of Employees: 219

• Price / Volume Information    Yesterday's Closing Price: $1.21 Daily Weekly Monthly 20 Day Moving Average: 33,166 shares Shares Outstanding: 6.26 (millions) Market Capitalization: $7.58 (millions) Beta: 0.35 52 Week High: $4.96 52 Week Low: $1.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -30.06% -29.32% 12 Week -50.13% -51.34% Year To Date -66.20% -70.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1535 Faraday Ave - Carlsbad,CA 92008 USA ph: 760-736-7700 fax: 760-744-9589 investor@nai-online.com http://www.nai-online.com

• General Corporate Information    Officers Mark A. LeDoux - Chief Executive Officer and Chairman of the Board Kenneth E. Wolf - President and Chief Operating Officer Alan G. Dunn - Director L. Kay Matherly - Director Guru Ramanathan - Director Peer Information Natural Alternatives International, Inc. (GSAC) Natural Alternatives International, Inc. (CASIF) Natural Alternatives International, Inc. (ALCD.) Natural Alternatives International, Inc. (OMNN) Natural Alternatives International, Inc. (CGPI.) Natural Alternatives International, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 638842302 SIC: 2833 Fiscal Year Fiscal Year End: June Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/11/26 Share - Related Items Shares Outstanding: 6.26 Most Recent Split Date: 1.00 (0.02:1) Beta: 0.35 Market Capitalization: $7.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.15 Price/Cash Flow: - Price / Sales: 0.05 EPS Growth vs. Year Ago Period: -205.88% vs. Previous Quarter: 27.78% Sales Growth vs. Year Ago Period: 1.90% vs. Previous Quarter: -2.75% ROE 09/30/26 - - 06/30/26 - -16.51 03/31/26 - -12.21 ROA 09/30/26 - - 06/30/26 - -6.95 03/31/26 - -5.30 Current Ratio 09/30/26 - - 06/30/26 - 1.73 03/31/26 - 1.64 Quick Ratio 09/30/26 - - 06/30/26 - 0.92 03/31/26 - 0.87 Operating Margin 09/30/26 - - 06/30/26 - -7.22 03/31/26 - -5.76 Net Margin 09/30/26 - - 06/30/26 - -14.52 03/31/26 - -10.13 Pre-Tax Margin 09/30/26 - - 06/30/26 - -14.22 03/31/26 - -6.76 Book Value 09/30/26 - - 06/30/26 - 7.96 03/31/26 - 10.22 Inventory Turnover 09/30/26 - - 06/30/26 - 4.28 03/31/26 - 4.41 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.20 03/31/26 - 0.13 Debt-to-Capital 09/30/26 - - 06/30/26 - 16.96 03/31/26 - 11.74

Powered by Zacks Investment Research ©